Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Milestone Pharmaceuticals Inc (MIST)

Milestone Pharmaceuticals Inc (MIST)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.88 -1.37 (-60.89%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.86 -0.02 (-2.27%) 19:59 ET
Quote Overview for Fri, Mar 28th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.75
Day High
1.32
Open 0.76
Previous Close 2.25 2.25
Volume 33,525,699 33,525,699
Avg Vol 4,496,940 4,496,940
Stochastic %K 36.30% 36.30%
Weighted Alpha -31.82 -31.82
5-Day Change -1.0200 (-53.68%) -1.0200 (-53.68%)
52-Week Range 0.7500 - 2.7500 0.7500 - 2.7500
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 46,952
  • Shares Outstanding, K 53,354
  • Annual Sales, $ 0 K
  • Annual Income, $ -41,520 K
  • EBIT $ -42 M
  • EBITDA $ -42 M
  • 60-Month Beta 1.83
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 9.13
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.68
  • Most Recent Earnings $-0.19 on 03/13/25
  • Next Earnings Date 05/12/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 334.23% ( +124.52%)
  • Historical Volatility 288.44%
  • IV Percentile 92%
  • IV Rank 39.64%
  • IV High 695.03% on 04/05/24
  • IV Low 97.25% on 12/31/24
  • Put/Call Vol Ratio 0.28
  • Today's Volume 4,067
  • Volume Avg (30-Day) 1,568
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 20,642
  • Open Int (30-Day) 14,303

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.22
  • Number of Estimates 4
  • High Estimate -0.18
  • Low Estimate -0.30
  • Prior Year -0.21
  • Growth Rate Est. (year over year) -4.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7500 +17.33%
on 03/28/25
Period Open: 1.6300
2.4991 -64.79%
on 03/17/25
-0.7500 (-46.01%)
since 02/28/25
3-Month
0.7500 +17.33%
on 03/28/25
Period Open: 2.1500
2.7500 -68.00%
on 12/31/24
-1.2700 (-59.07%)
since 12/27/24
52-Week
0.7500 +17.33%
on 03/28/25
Period Open: 1.7900
2.7500 -68.00%
on 12/31/24
-0.9100 (-50.84%)
since 03/28/24

Most Recent Stories

More News
Milestone Pharmaceuticals Stock Plunges 60% After FDA Declines To Approve Its Cardamyst Nasal Spray – But Retail’s Positive

The FDA said an inspection is required at a facility where the company performed release testing for the product to ensure it complies with Current Good Manufacturing Practices.

MIST : 0.8800 (-60.89%)
GWX : 32.23 (-1.29%)
FDA Issues Complete Response Letter for Etripamil for PSVT

MIST : 0.8800 (-60.89%)
Milestone Pharmaceuticals to Present Clinical Data on Etripamil at the American College of Cardiology

MIST : 0.8800 (-60.89%)
Milestone Pharmaceuticals: Q4 Earnings Snapshot

Milestone Pharmaceuticals: Q4 Earnings Snapshot

MIST : 0.8800 (-60.89%)
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Regulatory and Corporate Update

MIST : 0.8800 (-60.89%)
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MIST : 0.8800 (-60.89%)
Milestone® Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference

MIST : 0.8800 (-60.89%)
Milestone® Pharmaceuticals Notice of Allowance on New U.S. Patent for Etripamil

MIST : 0.8800 (-60.89%)
Milestone Pharmaceuticals to Host Commercial Launch Plan Investor Event in New York on February 25, 2025

MIST : 0.8800 (-60.89%)
Milestone Pharmaceuticals Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in NYC

MIST : 0.8800 (-60.89%)

Business Summary

Milestone Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. The company's lead product candidate consists of MSP-2017, a nasal spray. Milestone Pharmaceuticals...

See More

Key Turning Points

3rd Resistance Point 1.7867
2nd Resistance Point 1.5533
1st Resistance Point 1.2167
Last Price 0.8800
1st Support Level 0.6467
2nd Support Level 0.4133
3rd Support Level 0.0767

See More

52-Week High 2.7500
Fibonacci 61.8% 1.9860
Fibonacci 50% 1.7500
Fibonacci 38.2% 1.5140
Last Price 0.8800
52-Week Low 0.7500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies